HeartBeam rises on new CEO appointment
** Shares of heart device maker HeartBeam BEAT.O up 3.51% at
$2.34
** Co appoints Robert Eno as new CEO, replacing Branislav
Vajdic as CEO
** Eno joined Co as President in January 2023; Branislav
Vajdic to move into role of President
** Co continues to work towards FDA 510(k) clearance for its
vector-based technology, which captures the heart’s electrical
signals from three dimensions
** Including session's move, stocks down 0.43% YTD
(Reporting by Khusbu Jena in Bengaluru)
((Khusbu.Jena@thomsonreuters.com;))
Recent news on Heartbeam
See all newsBrief: Heartbeam Announces Strategic Shift To Accelerate Global Adoption Of Its Ambulatory ECG Signal Platform And Leadership Transition
Brief: Heartbeam Reports First Quarter 2026 Results
HeartBeam Q1 net loss narrows as commercialization advances
Brief: Heartbeam Initiates Pilot Study Of First On-Demand 12-Lead ECG Patch To Detect Ischemia Outside The Clinic
Brief: Heartbeam Expands Commercial Presence Across Four Key U.S. Markets With Addition Of Premier Concierge Practice